CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.58
3.33%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.06
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Orgenesis Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 0.6
Open* 0.6
1-Year Change* -56.52%
Day's Range* 0.58 - 0.61
52 wk Range 0.38-2.64
Average Volume (10 days) 306.40K
Average Volume (3 months) 1.87M
Market Cap 19.24M
P/E Ratio -100.00K
Shares Outstanding 28.75M
Revenue 35.63M
EPS -0.52
Dividend (Yield %) N/A
Beta 1.02
Next Earnings Date Nov 8, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 29, 2023 0.58 -0.02 -3.33% 0.60 0.61 0.58
Sep 28, 2023 0.60 -0.02 -3.23% 0.62 0.63 0.60
Sep 27, 2023 0.60 0.00 0.00% 0.60 0.60 0.60
Sep 26, 2023 0.58 -0.02 -3.33% 0.60 0.60 0.58
Sep 25, 2023 0.60 -0.01 -1.64% 0.61 0.61 0.60
Sep 22, 2023 0.61 0.02 3.39% 0.59 0.64 0.57
Sep 21, 2023 0.59 -0.04 -6.35% 0.63 0.63 0.59
Sep 20, 2023 0.57 -0.05 -8.06% 0.62 0.62 0.57
Sep 19, 2023 0.60 -0.04 -6.25% 0.64 0.65 0.59
Sep 18, 2023 0.68 0.03 4.62% 0.65 0.71 0.65
Sep 15, 2023 0.65 0.02 3.17% 0.63 0.66 0.63
Sep 14, 2023 0.68 0.02 3.03% 0.66 0.69 0.66
Sep 13, 2023 0.69 0.03 4.55% 0.66 0.70 0.66
Sep 12, 2023 0.67 0.01 1.52% 0.66 0.70 0.66
Sep 11, 2023 0.67 -0.05 -6.94% 0.72 0.76 0.67
Sep 8, 2023 0.70 0.06 9.37% 0.64 0.70 0.64
Sep 7, 2023 0.63 -0.05 -7.35% 0.68 0.68 0.61
Sep 6, 2023 0.67 -0.06 -8.22% 0.73 0.73 0.66
Sep 5, 2023 0.69 0.12 21.05% 0.57 0.80 0.57
Sep 1, 2023 0.56 0.06 12.00% 0.50 0.59 0.50

Orgenesis Inc. Events

Time (UTC) Country Event
Wednesday, November 8, 2023

Time (UTC)

10:59

Country

US

Event

Q3 2023 Orgenesis Inc Earnings Release
Q3 2023 Orgenesis Inc Earnings Release

Forecast

-

Previous

-
Friday, December 15, 2023

Time (UTC)

15:00

Country

US

Event

Orgenesis Inc Annual Shareholders Meeting
Orgenesis Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 36.025 35.502 7.652 3.899 1.852
Revenue 36.025 35.502 7.652 3.899 1.852
Cost of Revenue, Total 1.633 1.221
Gross Profit 34.392 0.631
Total Operating Expense 44.679 54.167 103.433 25.874 4.815
Selling/General/Admin. Expenses, Total 31.926 14.091 15.395 10.19 1.883
Research & Development 9.169 36.347 87.056 15.453 1.635
Depreciation / Amortization 0.961 1.864 1.182 1.064 0.203
Operating Income -8.654 -18.665 -95.781 -21.975 -2.963
Interest Income (Expense), Net Non-Operating -3.477 -1.789 -1.308 -0.956 -0.035
Other, Net 0.171 2.503 0.353 0.113 0.008
Net Income Before Taxes -11.96 -17.951 -96.736 -22.818 -2.99
Net Income After Taxes -12.169 -18.059 -95.127 -22.589 -2.907
Net Income Before Extra. Items -14.889 -18.053 -95.088 -22.49 -2.744
Net Income -14.889 -18.053 1.11 -24.121 -2.744
Income Available to Common Excl. Extra. Items -14.889 -18.053 -95.088 -22.49 -2.744
Income Available to Common Incl. Extra. Items -14.889 -18.053 1.11 -24.121 -2.744
Diluted Net Income -14.889 -18.053 1.11 -24.121 -2.744
Diluted Weighted Average Shares 25.0963 24.2737 21.3203 15.908 15.423
Diluted EPS Excluding Extraordinary Items -0.59328 -0.74373 -4.45997 -1.41375 -0.17792
Diluted Normalized EPS -0.56763 -0.69379 -4.45997 -1.41375 -0.17792
Unusual Expense (Income) 0.99 1.865
Other Operating Expenses, Total 0 -0.2 -0.833 -0.127
Minority Interest -2.72 0.006 0.039 0.099 0.163
Dividends per Share - Common Stock Primary Issue 0
Total Extraordinary Items 0 96.198 -1.631
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 6.975 7.044 13.624 7.988 7.201
Revenue 6.975 7.044 13.624 7.988 7.201
Total Operating Expense 9.893 10.532 14.303 7.995 11.933
Selling/General/Admin. Expenses, Total 3.165 3.818 10.539 6.339 7.401
Research & Development 3.606 3.448 2.064 1.07 3.88
Depreciation / Amortization 0.361 0.342 0.239 0.24 0.241
Other Operating Expenses, Total -0.06 -0.081
Operating Income -2.918 -3.488 -0.679 -0.007 -4.732
Interest Income (Expense), Net Non-Operating -0.65 -0.645 -0.592 -1.375 -0.756
Other, Net -0.002 0.001 0.171 -0.001 0.007
Net Income Before Taxes -3.57 -4.132 -1.1 -1.383 -5.481
Net Income After Taxes -3.661 -4.261 -1.272 -1.408 -5.492
Minority Interest -0.466 0.072 -2.825 0.052 0.065
Net Income Before Extra. Items -4.127 -4.189 -4.097 -1.356 -5.427
Total Extraordinary Items
Net Income -4.127 -4.189 -4.097 -1.356 -5.427
Income Available to Common Excl. Extra. Items -4.127 -4.189 -4.097 -1.356 -5.427
Income Available to Common Incl. Extra. Items -4.127 -4.189 -4.097 -1.356 -5.427
Diluted Net Income -4.127 -4.189 -4.097 -1.356 -5.427
Diluted Weighted Average Shares 28.3578 26.2469 25.5507 25.4039 24.8208
Diluted EPS Excluding Extraordinary Items -0.14553 -0.1596 -0.16035 -0.05338 -0.21865
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.15495 -0.15259 -0.13465 -0.05389 -0.21865
Unusual Expense (Income) -0.411 0.283 1.01 -0.02
Cost of Revenue, Total 3.232 2.722 0.451 0.366 0.411
Gross Profit 3.743 4.322 13.173 7.622 6.79
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 46.318 25.758 50.077 78.348 28.058
Cash and Short Term Investments 5.311 5.473 44.923 0.107 14.612
Cash & Equivalents 5.311 5.473 44.923 0.107 14.612
Total Receivables, Net 38.871 18.478 3.254 2.035 10.267
Accounts Receivable - Trade, Net 36.183 15.245 3.085 1.831 3.226
Total Inventory 0.12 0.118 0.185 0.136 1.66
Prepaid Expenses 0.958 1.188 1.07 0.382 1.132
Total Assets 90.928 59.841 77.684 92.495 73.876
Property/Plant/Equipment, Total - Net 25.138 11.286 4.547 3.03 12.458
Goodwill, Net 8.187 8.403 8.745 4.812 15.266
Intangibles, Net 9.694 11.821 13.023 3.348 16.642
Long Term Investments 0.135 0.152 0.175
Other Long Term Assets, Total 1.456 1.168 1.117 0.334 0.44
Total Current Liabilities 15.91 15.365 16.285 42.434 17.161
Accounts Payable 4.429 5.238 8.649 5.549 4.583
Accrued Expenses 4.98 2.873 2.74 3.644 4.551
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 4.564 5.903 4.138 0.807 1.249
Other Current Liabilities, Total 1.937 1.351 0.758 32.434 6.778
Total Liabilities 63.367 21.353 25.105 87.018 47.771
Total Long Term Debt 13.438 4.895 7.264 12.143 3.508
Long Term Debt 13.343 4.854 7.2 12.143 2.847
Deferred Income Tax 0.058 1.656
Minority Interest 31.713 0.143 0.149 31.556 24.869
Other Liabilities, Total 2.306 0.95 1.407 0.827 0.577
Total Equity 27.561 38.488 52.579 5.477 26.105
Common Stock 0.003 0.003 0.003 0.002 0.002
Additional Paid-In Capital 150.355 145.916 140.397 94.691 90.597
Retained Earnings (Accumulated Deficit) -121.261 -106.372 -88.319 -89.429 -65.163
Other Equity, Total -0.27 0.207 0.748 0.213 0.669
Total Liabilities & Shareholders’ Equity 90.928 59.841 77.684 92.495 73.876
Total Common Shares Outstanding 25.5458 24.3361 24.1678 16.141 15.5403
Other Current Assets, Total 1.058 0.501 0.645 75.688 0.387
Note Receivable - Long Term 1.253 2.623 1.012
Capital Lease Obligations 0.095 0.041 0.064 0.661
Property/Plant/Equipment, Total - Gross 29.09 14.226 6.736 4.468
Accumulated Depreciation, Total -3.952 -2.94 -2.189 -1.438
Treasury Stock - Common -1.266 -1.266 -0.25 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 49.45 46.318 31.856 25.458 24.01
Cash and Short Term Investments 2.674 5.311 3.015 2.303 1.123
Cash & Equivalents 2.674 5.311 3.015 2.303 1.123
Total Receivables, Net 40.464 38.871 26.395 21.798 20.846
Accounts Receivable - Trade, Net 37.739 36.183 23.744 18.786 17.075
Total Inventory 0.128 0.12 0.095 0.107 0.113
Prepaid Expenses 5.127 0.958 0.899 0.793 1.438
Other Current Assets, Total 1.057 1.058 1.452 0.457 0.49
Total Assets 93.267 90.928 70.69 62.799 58.538
Property/Plant/Equipment, Total - Net 24.712 25.138 17.566 15.145 11.99
Goodwill, Net 8.069 8.187 7.764 8.174 8.329
Intangibles, Net 9.43 9.694 10.72 11.207 11.539
Long Term Investments 0.136 0.135 1.739 1.75 1.574
Other Long Term Assets, Total 1.47 1.456 1.045 1.065 1.096
Total Current Liabilities 13.938 15.91 34.168 16.245 15.253
Accounts Payable 4.387 4.429 4.538 5.203 6.933
Accrued Expenses 5.041 4.98 5.627 4.16 3.568
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2.376 4.564 22.504 5.585 3.375
Other Current Liabilities, Total 2.134 1.937 1.499 1.297 1.377
Total Liabilities 65.6 63.367 40.478 31.046 23.836
Total Long Term Debt 17.369 13.438 5.186 13.972 7.58
Long Term Debt 17.29 13.343 5.162 13.943 7.544
Capital Lease Obligations 0.079 0.095 0.024 0.029 0.036
Minority Interest 31.641 31.713 0.038 0.09 0.155
Other Liabilities, Total 2.652 2.306 1.086 0.739 0.848
Total Equity 27.667 27.561 30.212 31.753 34.702
Common Stock 0.003 0.003 0.003 0.003 0.003
Additional Paid-In Capital 154.691 150.355 149.465 149.094 146.29
Retained Earnings (Accumulated Deficit) -125.45 -121.261 -117.164 -115.808 -110.381
Treasury Stock - Common -1.266 -1.266 -1.266 -1.266 -1.266
Other Equity, Total -0.311 -0.27 -0.826 -0.27 0.056
Total Liabilities & Shareholders’ Equity 93.267 90.928 70.69 62.799 58.538
Total Common Shares Outstanding 27.8615 25.5458 25.5458 24.8208 24.8208
Note Receivable - Long Term 0 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -12.169 -18.059 0.579 -26.041 -2.907
Cash From Operating Activities -24.924 -26.866 -78.046 -13.22 -1.077
Cash From Operating Activities 1.978 1.864 1.435 3.806 0.265
Deferred Taxes -0.103 0 -1.378 0.304 -0.058
Non-Cash Items 5.246 4.726 -76.784 5.717 0.746
Changes in Working Capital -19.876 -15.397 -1.898 2.994 0.877
Cash From Investing Activities -14.133 -12.384 105.61 -13.778 -0.592
Capital Expenditures -12.416 -7.866 -1.525 -12.129 -0.535
Other Investing Cash Flow Items, Total -1.717 -4.518 107.135 -1.649 -0.057
Cash From Financing Activities 39.578 -0.106 5.881 24.098 0.197
Financing Cash Flow Items 20.593 13.2 0
Issuance (Retirement) of Stock, Net 2.181 0.91 8.488 0
Issuance (Retirement) of Debt, Net 16.804 -1.016 -2.607 10.898 0.197
Foreign Exchange Effects -0.126 -0.238 0.082 -0.058 0.015
Net Change in Cash 0.395 -39.594 33.527 -2.958 -1.457
Cash Taxes Paid 0 0.156
Cash Interest Paid 0.458 0 0.157
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -4.261 -12.169 -10.897 -9.489 -3.997
Cash From Operating Activities -7.24 -24.924 -14.163 -9.206 -2.792
Cash From Operating Activities 0.578 1.978 1.463 0.975 0.474
Deferred Taxes 0.003 -0.103
Non-Cash Items 0.277 5.246 2.937 2.014 0.963
Changes in Working Capital -3.837 -19.876 -7.666 -2.706 -0.232
Cash From Investing Activities -1.307 -14.133 -7.458 -4.863 -1.613
Capital Expenditures -1.285 -12.416 -6.971 -4.352 -0.902
Other Investing Cash Flow Items, Total -0.022 -1.717 -0.487 -0.511 -0.711
Cash From Financing Activities 5.91 39.578 20.095 10.906 0.001
Financing Cash Flow Items 20.593 1.084 0
Issuance (Retirement) of Stock, Net 3.441 2.181 2.181 2.181 0.006
Issuance (Retirement) of Debt, Net 2.469 16.804 16.83 8.725 -0.005
Foreign Exchange Effects -0.001 -0.126 0.019 -0.051 0.043
Net Change in Cash -2.638 0.395 -1.507 -3.214 -4.361
Cash Interest Paid 0.785

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Orgenesis Inc. Company profile

About Orgenesis Inc

Orgenesis Inc. is a biotech company operating to unlock the potential of cell and gene therapies (CGTs). The Company is focused on autologous (using the patient’s own cells) therapies with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment. The Company has developed a Point of Care Platform comprised of three components: POCare Therapies, POCare Technologies and POCare Network. Its therapeutic portfolio pipeline is diverse and addresses various clinical needs. POCare Technology uses automated systems across a collaborative POCare Network via a combination of science, technology, engineering and networking.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Orgenesis Inc revenues increased from $5.4M to $28.6M. Net loss before extraordinary items decreased 70% to $13M. Revenues reflect POC Services segment increase from $4.3M to $17.1M, Cell process development services segment increase from $1.1M to $11.5M. Lower net loss reflects Other research and development expenses decrease of 43% to $5.6M (expense).

Equity composition

Common Stock $.001 Par, 4/13, 1.75B auth., 49,617,903 issd. Insider owns approx.50.56% Effective August 31, 2011 effected a 35 to one forward stock split

Industry: Medical Equipment, Supplies & Distribution (NEC)

20271 Goldenrod Lane
GERMANTOWN
MARYLAND 20876
US

Income Statement

  • Annual
  • Quarterly

News

How to Trade The Triple Top

Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

14:13, 27 September 2023
USA flag on the background of stock charts. Financial system in USA

Q4 lookahead: US indices starting to show signs of trouble?

US indices start to draw attention as traders focus on the outlook for Q4.

07:20, 27 September 2023

USD/JPY Climbs Towards Key Highs

USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

11:32, 26 September 2023

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

People also watch

BTC/USD

28,022.20 Price
+3.360% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

XRP/USD

0.53 Price
+1.300% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

Oil - Crude

90.30 Price
+0.300% 1D Chg, %
Long position overnight fee 0.0661%
Short position overnight fee -0.0881%
Overnight fee time 21:00 (UTC)
Spread 0.030

US100

14,830.20 Price
+0.630% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading